PHARMACARE ApS Financials, key figures and credit report
Gross profit 272.4 kDKK FY 2025 +279.2% vs 2024
EBIT 272.4 kDKK FY 2025 +33,822% vs 2024
Net debt - 378.8 kDKK FY 2025 +24% vs 2024
Quick ratio 5.2 FY 2025 +4.1 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 797.50 | 371.72 | 440.35 | 71.84 | 272.39 |
| Employee benefit expenses | - 492.34 | - 423.87 | - 411.56 | -71.04 | |
| EBIT | 305.16 | -52.15 | 28.79 | 0.80 | 272.39 |
| Other financial income | 3.79 | ||||
| Other financial expenses | -7.10 | -6.02 | -1.33 | -2.05 | |
| Pre-tax profit | 298.06 | -54.38 | 27.46 | -1.25 | 272.39 |
| Income taxes | -49.42 | 11.52 | -6.24 | 0.27 | -60.42 |
| Net earnings | 248.64 | -42.86 | 21.23 | -0.97 | 211.97 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 29.94 | 29.94 | |||
| Investments total | 29.94 | 29.94 | |||
| Non-current loans receivable | 29.94 | ||||
| Long term receivables total | 29.94 | ||||
| Inventories total | |||||
| Current trade debtors | 821.23 | 1 154.42 | 986.31 | 247.28 | |
| Prepayments and accrued income | 5.39 | 8.22 | 28.14 | 1.39 | |
| Current other receivables | 45.05 | 33.11 | 19.29 | 14.07 | |
| Current deferred tax assets | 12.27 | 23.80 | 17.56 | 17.83 | |
| Short term receivables total | 838.89 | 1 231.49 | 1 065.12 | 285.79 | 14.07 |
| Cash and bank deposits | 103.61 | 126.39 | 33.02 | 498.62 | 378.83 |
| Cash and cash equivalents | 103.61 | 126.39 | 33.02 | 498.62 | 378.83 |
| Balance sheet total (assets) | 972.45 | 1 387.81 | 1 128.07 | 784.41 | 392.90 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Retained earnings | - 245.26 | 3.38 | -39.48 | -18.25 | -19.23 |
| Profit of the financial year | 248.64 | -42.86 | 21.23 | -0.97 | 211.97 |
| Shareholders equity total | 128.38 | 85.52 | 106.75 | 105.77 | 317.74 |
| Non-current liabilities total | |||||
| Current trade creditors | 661.04 | 1 228.83 | 958.30 | 661.29 | 32.56 |
| Short-term deferred tax liabilities | 42.59 | ||||
| Other non-interest bearing current liabilities | 183.03 | 73.46 | 63.03 | 17.34 | |
| Current liabilities total | 844.06 | 1 302.29 | 1 021.33 | 678.64 | 75.16 |
| Balance sheet total (liabilities) | 972.45 | 1 387.81 | 1 128.07 | 784.41 | 392.90 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated